LOGIN
Assessing LIA efficacy with and without lipsomal bupivacaine addition in total knee arthroplasty
July 2019
Assessing LIA efficacy with and without lipsomal bupivacaine addition in total knee arthroplasty
Study Type:Randomized Trial
OE Level Evidence:2
Journal Level of Evidence:N/A
Local Infiltration Analgesia With Liposomal Bupivacaine Improves Early Outcomes After Total Knee Arthroplasty: 24-Hour Data From the PILLAR Study
J Arthroplasty. 2019 May;34(5):882-886.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
139 adult patients scheduled for primary, unilateral total knee arthroplasty (TKA) were randomized to receive a local infiltration analgesia (LIA) of aqueous bupivacaine (HCl) with or without liposomal bupivacaine (LB). The outcomes of interest included the proportion of opioid-free patients in the first 24 hours, total opioid consumption, area under curve (AUC) of pain intensity on a Visual Analo...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.